The Patent Finder

Terms ending in 2038

Janssen Research & Development, LLC

Every in-force patent on Janssen Research & Development, LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,077,106Cancer Treatment
In force
 · High confidence
Janssen Pharmaceutica N.V.In forceHigh confidence
US 12,006,302Tau Pet Imaging Ligands
In force
 · High confidence
Janssen Pharmaceutica N.V.In forceHigh confidence
US 10,995,149Antibodies That Specifically Bind PD-1 and Methods of Use
In force
 · High confidence
Janssen Biotech, Inc.In forceHigh confidence
US 11,786,665Grip Accessory for a Manual Injection Device
In force
 · High confidence
Janssen Pharmaceuticals, Inc.In forceHigh confidence
US 11,918,791Grip Accessory for a Manual Injection Device
In force
 · High confidence
Janssen Pharmaceuticals, Inc.In forceHigh confidence
US 11,059,850Novel Spirobicyclic Analogues
In force
 · High confidence
Janssen Pharmaceutica N.V.In forceHigh confidence
US D1,007,675Pharmaceutical Ingredient Mixing Training Device
In force
 · High confidence
Janssen Pharmaceutica N.V.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Janssen Research & Development, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited